CHICAGO--(BUSINESS WIRE)--SonarMD, the leading tech-enabled care coordination solution for digestive health, today announced additions to its executive team and board of directors. The company named A.R. Weiler to the role of Chief Executive Officer. Beth Houck, SonarMD’s Chief Customer Officer, was promoted to Chief Operating Officer. Additionally, the SonarMD Board of Directors welcomed Roy Beveridge, M.D.
Mr. Weiler brings extensive experience focused on the adoption of innovative, effective care delivery models to SonarMD as the company continues its next phase of growth. Most recently, Mr. Weiler served as CEO of Livio Health Group, a sister company of Blue Cross and Blue Shield of Minnesota, where he successfully led the development of a value-based, holistic care delivery service for patients with serious illness. Prior to that, Mr. Weiler was President & CEO of Healthsense, overseeing the company’s transformation and subsequent acquisition by GreatCall in 2016. He also contributed to the strategic development of Best Buy’s health business and Alphabet’s Verily and Google Health divisions. Mr. Weiler earned a degree in computer science from Harvard University.
“I am honored to work alongside this talented and dedicated team to continue SonarMD’s expansion to a growing number of patients, gastroenterology practices, and healthcare payers,” said Weiler. “We all are dedicated to the mission of improving patient health and satisfaction while simultaneously lowering medical spending and out-of-pocket costs. This is important work, and I am excited about the impact we can make in this area.”
Ms. Houck has more than 25 years of experience in healthcare, strategy, business development and operations. At SonarMD, Ms. Houck has been responsible for driving outstanding payer and provider relationships during a period of rapid growth, which includes expanded partnerships with major health insurers and some of the nation’s largest integrated gastrointestinal care networks.
Dr. Beveridge is a medical oncologist who has been in practice for over 20 years. He currently serves as a Consultant with Avalere Health. Previously, he led clinical operations for Humana as the Chief Medical Officer, and prior to that, as CMO for US Oncology, part of McKesson Health Solutions.
Tom Shehab, M.D., gastroenterologist and Managing Partner of SonarMD investor Arboretum Ventures, said, “This is an exciting, pivotal time for SonarMD. We are seeing a huge opportunity to remotely engage and monitor patients in the COVID-19 era and in a new normal. The addition of A.R. and Roy to our leadership team, and Beth’s promotion, demonstrate SonarMD’s commitment to continued growth in the market.”
“I’m thrilled to welcome A.R. and Roy to the SonarMD team, and I’m excited for Beth to serve in this new role as we continue our innovation and expansion,” added Lawrence Kosinski, MD, SonarMD’s Founder and Chief Medical Officer.
SonarMD is the leading tech-enabled care coordination solution for digestive health. SonarMD detects deterioration of high beta chronic conditions and makes it easier for patients and specialists to work together to address worsening symptoms sooner. High beta conditions, like inflammatory bowel disease, are symptomatic chronic conditions likely to deteriorate rapidly – leading to complications, hospitalizations, and highly variable per capita costs. The company contracts with payers and works directly with specialists to provide effective, value-based care. SonarMD is proud to be a CB Insights Digital Health 150 company for leading innovation in healthcare. For more information, visit SonarMD.com.